	1 2 3
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 3, 7.14% International Journal of Molecular Sciences 3 публикации, 7.14%
Molecules	Molecules, 2, 4.76% Molecules 2 публикации, 4.76%
European Journal of Organic Chemistry	European Journal of Organic Chemistry, 1, 2.38% European Journal of Organic Chemistry 1 публикация, 2.38%
Pharmacological Reviews	Pharmacological Reviews, 1, 2.38% Pharmacological Reviews 1 публикация, 2.38%
Current Medicinal Chemistry	Current Medicinal Chemistry, 1, 2.38% Current Medicinal Chemistry 1 публикация, 2.38%
Stroke	Stroke, 1, 2.38% Stroke 1 публикация, 2.38%
Therapeutic Advances in Neurological Disorders	Therapeutic Advances in Neurological Disorders, 1, 2.38% Therapeutic Advances in Neurological Disorders 1 публикация, 2.38%
Frontiers in Neurology	Frontiers in Neurology, 1, 2.38% Frontiers in Neurology 1 публикация, 2.38%
Acta Neurologica Belgica	Acta Neurologica Belgica, 1, 2.38% Acta Neurologica Belgica 1 публикация, 2.38%
Drugs in R and D	Drugs in R and D, 1, 2.38% Drugs in R and D 1 публикация, 2.38%
EMC - Neurologia	EMC - Neurologia, 1, 2.38% EMC - Neurologia 1 публикация, 2.38%
Clinical Neurology and Neurosurgery	Clinical Neurology and Neurosurgery, 1, 2.38% Clinical Neurology and Neurosurgery 1 публикация, 2.38%
Life Sciences	Life Sciences, 1, 2.38% Life Sciences 1 публикация, 2.38%
Toxicology and Applied Pharmacology	Toxicology and Applied Pharmacology, 1, 2.38% Toxicology and Applied Pharmacology 1 публикация, 2.38%
Pharmacological Research	Pharmacological Research, 1, 2.38% Pharmacological Research 1 публикация, 2.38%
Liver Research	Liver Research, 1, 2.38% Liver Research 1 публикация, 2.38%
Journal of Catalysis	Journal of Catalysis, 1, 2.38% Journal of Catalysis 1 публикация, 2.38%
Brain and Behavior	Brain and Behavior, 1, 2.38% Brain and Behavior 1 публикация, 2.38%
Chemical Biology and Drug Design	Chemical Biology and Drug Design, 1, 2.38% Chemical Biology and Drug Design 1 публикация, 2.38%
Journal of Clinical Pharmacy and Therapeutics	Journal of Clinical Pharmacy and Therapeutics, 1, 2.38% Journal of Clinical Pharmacy and Therapeutics 1 публикация, 2.38%
Organic Letters	Organic Letters, 1, 2.38% Organic Letters 1 публикация, 2.38%
RSC Advances	RSC Advances, 1, 2.38% RSC Advances 1 публикация, 2.38%
Nosotchu	Nosotchu, 1, 2.38% Nosotchu 1 публикация, 2.38%
Nevrologiya, Neiropsikhiatriya, Psikhosomatika	Nevrologiya, Neiropsikhiatriya, Psikhosomatika, 1, 2.38% Nevrologiya, Neiropsikhiatriya, Psikhosomatika 1 публикация, 2.38%
Israel Journal of Chemistry	Israel Journal of Chemistry, 1, 2.38% Israel Journal of Chemistry 1 публикация, 2.38%
Oxidative Medicine and Cellular Longevity	Oxidative Medicine and Cellular Longevity, 1, 2.38% Oxidative Medicine and Cellular Longevity 1 публикация, 2.38%
Experientia supplementum (2012)	Experientia supplementum (2012), 1, 2.38% Experientia supplementum (2012) 1 публикация, 2.38%
Meditsinskiy sovet = Medical Council	Meditsinskiy sovet = Medical Council, 1, 2.38% Meditsinskiy sovet = Medical Council 1 публикация, 2.38%
Nervno-Myshechnye Bolezni	Nervno-Myshechnye Bolezni, 1, 2.38% Nervno-Myshechnye Bolezni 1 публикация, 2.38%
	1 2 3

Издатели

	1 2 3 4 5 6 7 8 9
Elsevier	Elsevier, 9, 21.43% Elsevier 9 публикаций, 21.43%
Wiley	Wiley, 5, 11.9% Wiley 5 публикаций, 11.9%
MDPI	MDPI, 5, 11.9% MDPI 5 публикаций, 11.9%
Springer Nature	Springer Nature, 3, 7.14% Springer Nature 3 публикации, 7.14%
Frontiers Media S.A.	Frontiers Media S.A., 2, 4.76% Frontiers Media S.A. 2 публикации, 4.76%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 2, 4.76% Cold Spring Harbor Laboratory 2 публикации, 4.76%
American Society for Pharmacology and Experimental Therapeutics	American Society for Pharmacology and Experimental Therapeutics, 1, 2.38% American Society for Pharmacology and Experimental Therapeutics 1 публикация, 2.38%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 1, 2.38% Bentham Science Publishers Ltd. 1 публикация, 2.38%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 1, 2.38% Ovid Technologies (Wolters Kluwer Health) 1 публикация, 2.38%
SAGE	SAGE, 1, 2.38% SAGE 1 публикация, 2.38%
American Chemical Society (ACS)	American Chemical Society (ACS), 1, 2.38% American Chemical Society (ACS) 1 публикация, 2.38%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 1, 2.38% Royal Society of Chemistry (RSC) 1 публикация, 2.38%
Japan Stroke Society	Japan Stroke Society, 1, 2.38% Japan Stroke Society 1 публикация, 2.38%
IMA Press, LLC	IMA Press, LLC, 1, 2.38% IMA Press, LLC 1 публикация, 2.38%
Hindawi Limited	Hindawi Limited, 1, 2.38% Hindawi Limited 1 публикация, 2.38%
Remedium, Ltd.	Remedium, Ltd., 1, 2.38% Remedium, Ltd. 1 публикация, 2.38%
Publishing House ABV Press	Publishing House ABV Press, 1, 2.38% Publishing House ABV Press 1 публикация, 2.38%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii	Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii, 1, 2.38% Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii 1 публикация, 2.38%
Pleiades Publishing	Pleiades Publishing, 1, 2.38% Pleiades Publishing 1 публикация, 2.38%
Taylor & Francis	Taylor & Francis, 1, 2.38% Taylor & Francis 1 публикация, 2.38%
	1 2 3 4 5 6 7 8 9

Мы не учитываем публикации, у которых нет DOI.
Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.

Войти с ORCID

Метрики

Цитировать

ГОСТ |

Цитировать

ГОСТ Скопировать

Miyaji Y. et al. Effect of Edaravone on Favorable Outcome in Patients with Acute Cerebral Large Vessel Occlusion: Subanalysis of RESCUE-Japan Registry // Neurologia Medico-Chirurgica. 2015. Vol. 55. No. 3. pp. 241-247.

ГОСТ со всеми авторами (до 50) Скопировать

Miyaji Y., Yoshimura S., Sakai N., Yamagami H., Egashira Y., Shirakawa M., Uchida K., KAGEYAMA H., TOMOGANE Y. Effect of Edaravone on Favorable Outcome in Patients with Acute Cerebral Large Vessel Occlusion: Subanalysis of RESCUE-Japan Registry // Neurologia Medico-Chirurgica. 2015. Vol. 55. No. 3. pp. 241-247.

RIS |

Цитировать

RIS Скопировать

TY - JOUR

DO - 10.2176/nmc.ra.2014-0219

UR - https://www.jstage.jst.go.jp/article/nmc/55/3/55_ra.2014-0219/_article

TI - Effect of Edaravone on Favorable Outcome in Patients with Acute Cerebral Large Vessel Occlusion: Subanalysis of RESCUE-Japan Registry

T2 - Neurologia Medico-Chirurgica

AU - Miyaji, Yuki

AU - Yoshimura, Shinichi

AU - Sakai, Nobuyuki

AU - Yamagami, Hiroshi

AU - Egashira, Yusuke

AU - Shirakawa, Manabu

AU - Uchida, Kazutaka

AU - KAGEYAMA, Hirohito

AU - TOMOGANE, Yusuke

PY - 2015

DA - 2015/02/19

PB - Japan Neurosurgical Society

SP - 241-247

IS - 3

VL - 55

PMID - 25739433

SN - 0387-2572

SN - 0470-8105

SN - 1349-8029

ER -

BibTex |

Цитировать

BibTex (до 50 авторов) Скопировать

@article{2015_Miyaji,

author = {Yuki Miyaji and Shinichi Yoshimura and Nobuyuki Sakai and Hiroshi Yamagami and Yusuke Egashira and Manabu Shirakawa and Kazutaka Uchida and Hirohito KAGEYAMA and Yusuke TOMOGANE},

title = {Effect of Edaravone on Favorable Outcome in Patients with Acute Cerebral Large Vessel Occlusion: Subanalysis of RESCUE-Japan Registry},

journal = {Neurologia Medico-Chirurgica},

year = {2015},

volume = {55},

publisher = {Japan Neurosurgical Society},

month = {feb},

url = {https://www.jstage.jst.go.jp/article/nmc/55/3/55_ra.2014-0219/_article},

number = {3},

pages = {241--247},

doi = {10.2176/nmc.ra.2014-0219}

}

MLA

Цитировать

MLA Скопировать

Miyaji, Yuki, et al. “Effect of Edaravone on Favorable Outcome in Patients with Acute Cerebral Large Vessel Occlusion: Subanalysis of RESCUE-Japan Registry.” Neurologia Medico-Chirurgica, vol. 55, no. 3, Feb. 2015, pp. 241-247. https://www.jstage.jst.go.jp/article/nmc/55/3/55_ra.2014-0219/_article.

Издатель

Japan Neurosurgical Society

Журнал

Neurologia Medico-Chirurgica

scimago Q1

wos Q2

БС2

SJR

1.070

CiteScore

4.5

Impact factor

2.3

ISSN

03872572 (Print)

04708105 (Print)

13498029 (Electronic)